Gail Megason

979 total citations
34 papers, 425 citations indexed

About

Gail Megason is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gail Megason has authored 34 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gail Megason's work include Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Myeloid Leukemia Research (8 papers). Gail Megason is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Acute Myeloid Leukemia Research (8 papers). Gail Megason collaborates with scholars based in United States, Australia and South Korea. Gail Megason's co-authors include T. David Elkin, Cynthia Karlson, Suvankar Majumdar, Melissa A. Faith, Rathi V. Iyer, Lucio Miele, John Gibson, Jianwei Gu, Fang Chen and Michael J. Nowicki and has published in prestigious journals such as Blood, British Journal of Haematology and Journal of Pediatric Psychology.

In The Last Decade

Gail Megason

33 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail Megason United States 12 148 139 119 82 64 34 425
Alex Wing Kwan Leung Hong Kong 12 82 0.6× 111 0.8× 94 0.8× 47 0.6× 51 0.8× 51 380
Javier Monleón Spain 16 93 0.6× 92 0.7× 87 0.7× 64 0.8× 24 0.4× 36 549
Nazan Çetingül Türkiye 11 106 0.7× 120 0.9× 139 1.2× 72 0.9× 48 0.8× 36 408
Adebayo Olujohungbe United Kingdom 11 196 1.3× 237 1.7× 44 0.4× 59 0.7× 36 0.6× 15 489
Matthew M. K. Shing Hong Kong 12 124 0.8× 99 0.7× 81 0.7× 32 0.4× 38 0.6× 28 314
Abdulmohsen Al-Swailem Saudi Arabia 8 149 1.0× 107 0.8× 72 0.6× 60 0.7× 18 0.3× 13 633
Lucia De Zen Italy 11 61 0.4× 215 1.5× 174 1.5× 84 1.0× 60 0.9× 24 567
G Kardos Hungary 9 46 0.3× 226 1.6× 97 0.8× 62 0.8× 40 0.6× 28 391
José Carlos Morais Brazil 13 87 0.6× 52 0.4× 43 0.4× 59 0.7× 224 3.5× 37 468
Riad Sulaimani Saudi Arabia 5 89 0.6× 58 0.4× 57 0.5× 61 0.7× 19 0.3× 8 484

Countries citing papers authored by Gail Megason

Since Specialization
Citations

This map shows the geographic impact of Gail Megason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Megason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Megason more than expected).

Fields of papers citing papers by Gail Megason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail Megason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Megason. The network helps show where Gail Megason may publish in the future.

Co-authorship network of co-authors of Gail Megason

This figure shows the co-authorship network connecting the top 25 collaborators of Gail Megason. A scholar is included among the top collaborators of Gail Megason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail Megason. Gail Megason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Espinoza, Ingrid, et al.. (2018). Genetic Mutations in B-Acute Lymphoblastic Leukemia Among African American and European American Children. Clinical Lymphoma Myeloma & Leukemia. 18(12). e501–e508. 4 indexed citations
2.
Hicks, Chindo, Anna Sitthi-Amorn, Jessica Douglas, et al.. (2016). Molecular Analysis of Central Nervous System Disease Spectrum in Childhood Acute Lymphoblastic Leukemia. Clinical Medicine Insights Oncology. 10. 5–15. 10 indexed citations
3.
Zhang, Xu, et al.. (2014). Pediatric Osteosarcoma: A Single Institution’s Experience. Southern Medical Journal. 107(11). 671–675. 9 indexed citations
5.
Darwish, Mona, Gail Megason, Mary Lou Bond, et al.. (2014). Population pharmacokinetics and pharmacokinetics/pharmacodynamics of bendamustine in pediatric patients with relapsed/refractory acute leukemia. Current Medical Research and Opinion. 30(11). 2305–2315. 5 indexed citations
6.
Karlson, Cynthia, et al.. (2014). Development of the Family Symptom Inventory. Journal of Pediatric Hematology/Oncology. 37(2). 140–146. 13 indexed citations
7.
Fraser, Chris, Patrick A. Brown, Gail Megason, et al.. (2013). Open-label Bendamustine Monotherapy for Pediatric Patients With Relapsed or Refractory Acute Leukemia. Journal of Pediatric Hematology/Oncology. 36(4). e212–e218. 10 indexed citations
8.
Karlson, Cynthia, et al.. (2012). Examination of Risk and Resiliency in a Pediatric Sickle Cell Disease Population Using the Psychosocial Assessment Tool 2.0. Journal of Pediatric Psychology. 37(9). 1031–1040. 51 indexed citations
9.
Gordon, Catherine M., et al.. (2011). A Rare Case of Peripheral Neuropathy From Relapse of Acute Lymphoblastic Leukemia to the Brachial Plexus. Journal of Pediatric Hematology/Oncology. 34(2). e77–e79. 4 indexed citations
10.
Majumdar, Suvankar, Amy Morris, Claire C. Gordon, et al.. (2010). Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi. Haemophilia. 16(3). 455–459. 26 indexed citations
11.
Majumdar, Suvankar, Christopher A. Friedrich, Christian A. Koch, et al.. (2009). Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma. Pediatric Blood & Cancer. 54(3). 473–475. 13 indexed citations
12.
Brown, Kathy, Charu Subramony, Gail Megason, et al.. (2009). Hepatic Iron Overload in Children With Sickle Cell Anemia on Chronic Transfusion Therapy. Journal of Pediatric Hematology/Oncology. 31(5). 309–312. 47 indexed citations
13.
Majumdar, Suvankar, et al.. (2009). Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience. Bone Marrow Transplantation. 45(5). 895–900. 29 indexed citations
14.
Megason, Gail, et al.. (2008). Clofarabine-Induced Remission in Relapsed Pediatric Acute Myelogenous Leukemia. Blood. 112(11). 4042–4042. 1 indexed citations
15.
Elkin, T. David, et al.. (2006). Longitudinal neurocognitive outcome in an adolescent with Hurler-Scheie syndrome. Neuropsychiatric Disease and Treatment. 2(3). 381–386. 4 indexed citations
16.
Bomgaars, Lisa, Gail Megason, Jeanette Pullen, et al.. (2005). Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors. Pediatric Blood & Cancer. 47(2). 163–168. 2 indexed citations
17.
Megason, Gail, et al.. (2004). Recurrent Neuroblastoma With Gastric Invasion. Journal of Pediatric Hematology/Oncology. 26(8). 476–479. 1 indexed citations
18.
Webb, Patrick, T. David Elkin, Ronald S. Drabman, et al.. (2003). Improving Parent Participation at Pediatric Diabetes and Sickle Cell Appointments Using a Brief Intervention. Children s Health Care. 32(2). 125–136. 11 indexed citations
19.
Megason, Gail, et al.. (1996). SPECIFICITY OF HEMATOPOIETIC STEM CELL HOMING. Hematological Oncology. 14(1). 17–27. 23 indexed citations
20.
Smith, J. Clinton, et al.. (1994). Clinical Characteristics of Children With Hereditary Hemolytic Anemias and Aplastic Crisis: A 7-Year Review. Southern Medical Journal. 87(7). 702–708. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026